Studied for soft-tissue repair and mobility. For the injury that never quite forgave you.
TB-500 is a synthetic analog of Thymosin Beta-4, studied for its role in regulating G-actin sequestration and cytoskeletal dynamics. Research suggests it may activate angiogenic pathways through VEGF and MMP signaling, supporting endothelial cell migration and new vessel formation. Preclinical data also indicates engagement of anti-inflammatory cytokine pathways and extracellular matrix remodeling processes relevant to connective tissue biology. Intended for research purposes.


TB-500 is a synthetic analog of Thymosin Beta-4, studied for its role in regulating G-actin sequestration and cytoskeletal dynamics. Research suggests it activates angiogenic pathways through VEGF and MMP signaling, supporting endothelial cell migration and new vessel formation, alongside anti-inflammatory cytokine and extracellular matrix remodeling activity.
Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.